UBR5 and cancer: Overexpression of UBR5 has been demonstrated in several cancers, including breast [5, 6], ovarian [7], colorectal [8], pancreatic [9], and gastric cancers [10], and is closely associated with advanced clinical stage, distant metastasis, and shorter overall survival in patients.